PRL activates the cyclin D1 promoter via the Jak2/Stat pathway

Molecular Endocrinology

Volumn 16, Issue 4, 2002, Pages 774-784

  Brockman, Jennifer L ^a   Schroeder, Matthew D ^a   Schuler, Linda A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DACTINOMYCIN; PROLACTIN; STAT PROTEIN; STAT5 PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; BREAST CANCER; BREAST CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CHO CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0036214521     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.16.4.0817     Document Type: Article

References (69)

1. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women
2. Should prolactin be reconsidered as a therapeutic target in human breast cancer
3. The role of prolactin and growth hormone in breast cancer
4. Prolactin in human breast cancer development
5. Expression of prolactin and prolactin receptor in human breast carcinoma: Evidence for an autocrine/paracrine loop
6. Expression of prolactin and its receptor in human breast carcinoma
7. Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors vs. normal breast tissues
8. A specific role for cyclin D1 in mammary gland development
9. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse
10. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene
11. Specific protection against breast cancers by cyclin D1 ablation
12. Cyclin D1 protein expression and function in human breast cancer
13. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle
14. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
15. Lactogenic hormone signal transduction
16. From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models
17. Prolactin receptor signal transduction
18. The significance of tetramerization in promoter recruitment by Stat5
19. Transcriptional inhibition by Stat5 - Differential activities at growth-related vs. differentiation-specific promoters
20. Prolactin receptor is associated with c-src kinase in rat liver
21. fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes
22. Prolactin activates Ras via signaling proteins SHC, growth factor receptor bound 2, and son of sevenless
23. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells
24. Activation of raf-1 MEK, and MAP kinase in prolactin responsive mammary cells
25. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis
26. Prolactin stimulates activation of c-jun N-terminal kinase (JNK)
27. Prolactin-induced cell proliferation in PC12 cells depends on JNK but not ERK activation
28. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation
29. Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells
30. Prolactin modulates cell cycle regulators in mammary tumor epithelial cells
31. Inducible regulatory elements in the human cyclin D1 promoter
32. Developmental and environmental regulation of a mammary gland-specific nuclear factor essential for transcription of the gene encoding β-casein
33. Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation
34. Interactions among JANUS kinases and the prolactin (PRL) receptor in the regulation of a PRL response element
35. Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580
36. The role of STATs in transcriptional control and their impact on cellular function
37. Naturally occurring dominant negative variants of Stat5
38. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity
39. Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein
40. Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression - Impact of Stat5a gene disruption
41. Growth hormone activation of Stat 1, Stat 3, and Stat 5 in rat liver. Differential kinetics of hormone desensitization and growth hormone stimulation of both tyrosine phosphorylation and serine/threonine phosphorylation
42. STATs in oncogenesis
43. Transforming growth factor α and mouse models of human breast cancer
44. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells
45. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue
46. Stat5a is mandatory for adult mammary gland development and lactogenesis
47. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
48. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A
49. Multiple Stat complexes interact at the interferon regulatory factor-1 interferon-γ activation sequence in prolactin- stimulated Nb2 T cells
50. Multiple prolactin receptor cytoplasmic residues and Stat1 mediate PRL signaling to the interferon regulatory factor-1 promoter
51. Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPβ promoter suggests a new mechanism of transcriptional regulation by STAT3
52. Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice
53. Complex roles of Stat1 in regulating gene expression
54. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway
55. Transforming p21 ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions
56. Prolactin-independent modulation of the β-casein response element by Erk2 MAP kinase
57. Prolactin (PRL)-PRL receptor system increases cell proliferation involving JNK (c-Jun amino terminal kinase) and AP-1 activation: Inhibition by glucocorticoids
58. Janus kinase 2-dependent activation of p38 mitogen-activated protein kinase by growth hormone - Resultant transcriptional, activation of ATF-2 and chop, cytoskeletal re-organization and mitogenesis
59. WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: Role of activated STAT3 signaling
60. v-src signaling in breast cancer cells
61. Estrogen induction of the cyclin D1 promoter: Involvement of a cAMP response-like element
62. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: Role of estrogen receptor-Sp1 interactions
63. AP-1 blockade inhibits the growth of normal and malignant breast cells
64. Molecular cloning of the bovine prolactin receptor and distribution of prolactin and growth hormone receptor transcripts in fetal and utero-placental tissues
65. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6
66. Maximal activation of transcription by stat1 and stat3 requires both tyrosine and serine phosphorylation
67. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation
68. Construction of plasmids that express E. coli β-galactosidase in mammalian cells
69. Transcriptional regulation of interleukin-1β gene by interleukin-1β itself is mediated in part by Oct-1 in thymic stromal cells